FDA reminds providers of steps to prevent false positive antigen tests
The Food and Drug Administration yesterday reminded clinical laboratory staff and health care providers to follow recommended steps to prevent false positive results from antigen tests for the COVID-19 virus, citing reports of false positives in nursing homes and other settings.
The agency recommends users follow the test maker’s instructions for use; allow each specimen the proper time in the test device and for reading results; minimize cross-contamination risks; and consider confirming positive results with a reverse transcription polymerase chain reaction (RT-PCR) test within 48 hours, especially in low-incidence counties.
Related News Articles
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…